Spoken Alpha · Executive

George Yancopoulos

Bd. Co-Chair, President & CSOREGNREGENERON PHARMACEUTICALS, INC.

Current

Tracked since Dec 11, 2023

Tracked across 20 earnings calls in our data since 2021.

Role timeline

REGNREGENERON PHARMACEUTICALS, INC.
Current
Bd. Co-Chair, President & CSO
Dec 11, 2023 – Present · source: edgar_form4
REGNREGENERON PHARMACEUTICALS, INC.
President and Chief Scientific
Dec 13, 2018 – Mar 23, 2023 · source: edgar_form4
REGNREGENERON PHARMACEUTICALS, INC.
President & CSO
Dec 31, 2016 – Dec 18, 2017 · source: edgar_form4
REGNREGENERON PHARMACEUTICALS, INC.
President and CSO
Nov 2, 2015 – Dec 11, 2019 · source: edgar_form4
REGNREGENERON PHARMACEUTICALS, INC.
President Regeneron Laboratori
Oct 30, 2015 – Dec 15, 2016 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

20 calls

REGNQ1 FY2026Apr 29, 2026

REGENERON PHARMACEUTICALS, INC.

REGNQ4 FY2025Jan 30, 2026

REGENERON PHARMACEUTICALS, INC.

REGNQ3 FY2025Oct 28, 2025

REGENERON PHARMACEUTICALS, INC.

REGNQ2 FY2025Aug 1, 2025

REGENERON PHARMACEUTICALS, INC.

REGNQ1 FY2025Apr 29, 2025

REGENERON PHARMACEUTICALS, INC.